In a mouse model of Parkinson’s disease, metformin (150 mg/kg) reduced the amount of microglia, proinflammatory cytokines (TNF-α, IL-1β, and IL-6), and inducible nitric oxide synthase (iNOS) [61]. Here, IL1B is linked to Parkinson disease.